Global Health Ventures Inc. (the “Company”) is a specialty pharma with focus on the Over-The-Counter drug market. The Company has a new proprietary platform technology that delivers many approved drugs via the sublingual (under the tongue) route. This unique method delivers low dose drugs directly to the blood stream, bypassing all the side effects of digestive and liver system breakdowns, while maintaining product efficacy. The Company currently has five products in late stage development and several more underway.

www.globalhealth3000.com